China Life launches $737M semiconductor fund as Beijing urges 'patient capital'

China Life Insurance, the country's largest life insurer backed by the State Council, announced a 5 billion yuan (US$737 million) partnership fund to invest in semiconductor companies. The fund, formed with a China Life sister company, will target chip design firms with substantial technical know-how and R&D systems. This move aligns with Beijing's push for 'patient capital'—long-term investment willing to tolerate greater risk and longer return cycles. The Communist Party's theoretical journal Qiushi ran three consecutive commentaries last week by Xu Siwei, chairman of state-owned China Reform Holdings, urging such capital to support strategic industries amid global competition. The filings to Hong Kong and Shanghai bourses state that the insurer's involvement fulfills its responsibility to support national strategies and demonstrates its role as a provider of long-term capital.